These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23318963)

  • 1. [Clinical efficacy of high-dose cepharanthine for idiopathic thrombocytopenic purpura: retrospective multicenter analysis].
    Takahata M; Hashino S; Fujimoto K; Endo T; Kobayashi N; Kurosawa M; Iwasaki H; Miyake T; Kohda K; Maekawa I; Sasagawa H; Tsustumi Y; Miyagishima T; Tanaka J; Imamura M; Teshima T
    Rinsho Ketsueki; 2012 Dec; 53(12):1983-90. PubMed ID: 23318963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma.
    Tabata R; Tabata C; Tazoh A; Nagai T
    Int Immunopharmacol; 2012 Jul; 13(3):242-4. PubMed ID: 22561120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose Cepharanthin for pediatric chronic immune thrombocytopenia in Japan.
    Yamazaki T; Shibuya A; Ishii S; Miura N; Ohtake A; Sasaki N; Araki R; Ota Y; Fujiwara M; Miyajima Y; Uetake K; Hamahata K; Kato K; Kawakami K; Toyoda H; Moriguchi N; Okada M; Nishi M; Ogata Y; Takimoto T; Ohga S; Ohta S; Amemiya S
    Pediatr Int; 2017 Mar; 59(3):303-308. PubMed ID: 27596055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura.
    Saito N; Takemori N; Hirai K; Onodera R; Watanabe S; Kohgo Y
    Am J Hematol; 1996 Feb; 51(2):173-4. PubMed ID: 8579066
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
    Schiavotto C; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy.
    Kondo H; Iseki T; Goto S; Takaso T; Ohto M; Okuda K
    Int J Hematol; 1992 Jun; 55(3):293-300. PubMed ID: 1498320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of chronic idiopathic thrombocytopenic purpura in children.
    Bansal D; Bhamare TA; Trehan A; Ahluwalia J; Varma N; Marwaha RK
    Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura.
    Veneri D; Franchini M; Gottardi M; D'Adda M; Ambrosetti A; Krampera M; Zanetti F; Pizzolo G
    Haematologica; 2002 Nov; 87(11):1177-9. PubMed ID: 12414347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclic thrombocytopenia synchronizing with the menstrual cycle showing periodic phases of thrombocytopenia and rebound thrombocytosis].
    Kurihara T; Sumi M; Kaiume H; Takeda W; Kirihara T; Sato K; Ueki T; Hiroshima Y; Kobayashi H
    Rinsho Ketsueki; 2017; 58(3):243-245. PubMed ID: 28413179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor response to prednisolone of idiopathic thrombocytopenia with human T-lymphotropic virus type I infection.
    Matsushita K; Arima N; Ohtsubo H; Fujiwara H; Arimura K; Kukita T; Ozaki A; Hidaka S; Matsumoto T; Tei C
    Am J Hematol; 2002 Sep; 71(1):20-3. PubMed ID: 12221669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
    Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
    Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
    Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G
    N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.